Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-25-004605

Chief Executive Officer sold 30,601 shares at $0.58 ($17,773)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Rawcliffe Adrian Chief Executive Officer 2025-01-17 Sale −30,601 $0.58 $17,773 44,327 D: show line 1 in the form
Open-market sales · 30,601 sh · avg $0.58 · $17,773
Loading xslF345X05/tm253716-1_4seq1.xml…